‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: AHA Late-Breaker: SELECT – Semaglutide and CV Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes
30
00:00:00
/ 00:12:54
30